Nasdaq Prax News Today

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

HC Wainwright reaffirmed their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $105.00 price objective on the stock. Other analysts have also issued reports about the company. Wedbush boosted their price objective on Praxis Precision […]

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They presently have a $105.00 target price on the stock. HC Wainwright’s target price would indicate a potential upside of 98.56% from the company’s previous […]

Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $50.74, but opened at $52.12. Praxis Precision Medicines shares last traded at $51.46, with a volume of 28,341 shares trading hands. Analyst Upgrades and Downgrades Several research analysts recently […]

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $105.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 77.54% from the stock’s current price. A […]

In the 45 mg cohort, 100% of patients achieved a complete response In the 15 mg cohort, 80% of patients achieved a complete response and 20% achieved a...

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently have a $105.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 77.54% from the stock’s current price. A number […]

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 564,000 shares, a growth of 15.9% from the January 15th total of 486,700 shares. Approximately 7.1% of the shares of the company are sold short. Based on an […]

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 3,460,000 shares, a growth of 25.4% from the October 31st total of 2,760,000 shares. Based on an average trading volume of 737,900 shares, the short-interest […]

Praxis Precision Medicines Inc (NASDAQ: PRAX) has seen a decline in its stock price by -7.27 in relation to its previous close of 1.65. However, the company has experienced a -10.53% decline in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-08-28 that BOSTON, Aug. 2